Literature DB >> 12235716

Chorioamnionitis: elevated interleukin-6 and interleukin-8 concentrations in the lower uterine segment.

Marc J Willi1, Matthias Winkler, Dagmar-Christiane Fischer, Thorsten Reineke, Holger Maul, Werner Rath.   

Abstract

AIMS: To determine interleukin (IL)-6 and IL-8 concentrations in the lower uterine segment in patients with chorioamnionitis compared to those without.
METHODS: Biopsy specimens from the lower uterine segment of 33 patients with chorioamnionitis were matched to specimens of 33 patients without. The biopsies had been taken during cesarean section. The concentrations of IL-6 and IL-8 in protein extracts of these specimens were determined by enzyme linked immunosorbent assays.
RESULTS: Compared to the controls patients with chorioamnionitis showed significantly lower gestational age and higher parity, and were more likely to receive fenoterol or betamethasone. In the chorioamnionitis group the median IL-6 concentrations were higher than in the controls (61.5 and 19.4 pg/mg protein, respectively [p < 0.01]). The same applies to the median IL-8 concentrations (162.3 and 13.4 pg/mg protein, respectively [p < 0.001]).
CONCLUSIONS: To our knowledge this is the first study which could clearly demonstrate significantly increased IL-6 and IL-8 levels in the lower uterine segment of patients with chorioamnionitis. Increased concentrations of pro-inflammatory cytokines may play a pivotal role in cervical softening and dilatation during chorioamniotic infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235716     DOI: 10.1515/JPM.2002.042

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  6 in total

1.  Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques.

Authors:  Roberto Romero; Jezid Miranda; Juan P Kusanovic; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Alicia Martinez; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Majid Shaman; Kia Lannaman; Bo Hyun Yoon; Sonia S Hassan; Chong J Kim; Steven J Korzeniewski; Lami Yeo; Yeon Mee Kim
Journal:  J Perinat Med       Date:  2015-01       Impact factor: 1.901

2.  Clinical chorioamnionitis at term IX: in vivo evidence of intra-amniotic inflammasome activation.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Eli Maymon; Juan Pedro Kusanovic; Bogdan Panaitescu; Derek Miller; Percy Pacora; Adi L Tarca; Kenichiro Motomura; Offer Erez; Eunjung Jung; Sonia S Hassan; Chaur-Dong Hsu
Journal:  J Perinat Med       Date:  2019-04-24       Impact factor: 1.901

3.  Clinical Chorioamnionitis at Term: New Insights into the Etiology, Microbiology, and the Fetal, Maternal and Amniotic Cavity Inflammatory Responses.

Authors:  Roberto Romero; Nardhy Gomez-Lopez; Juan Pedro Kusanovic; Percy Pacora; Bogdan Panaitescu; Offer Erez; Bo Hyun Yoon
Journal:  Nogyogyaszati Szuleszeti Tovabbkepzo Szemle       Date:  2018-06

Review 4.  Sneathia: an emerging pathogen in female reproductive disease and adverse perinatal outcomes.

Authors:  Kevin R Theis; Violetta Florova; Roberto Romero; Andrei B Borisov; Andrew D Winters; Jose Galaz; Nardhy Gomez-Lopez
Journal:  Crit Rev Microbiol       Date:  2021-04-06       Impact factor: 7.624

5.  Clinical chorioamnionitis at term X: microbiology, clinical signs, placental pathology, and neonatal bacteremia - implications for clinical care.

Authors:  Roberto Romero; Percy Pacora; Juan Pedro Kusanovic; Eunjung Jung; Bogdan Panaitescu; Eli Maymon; Offer Erez; Susan Berman; David R Bryant; Nardhy Gomez-Lopez; Kevin R Theis; Gaurav Bhatti; Chong Jai Kim; Bo Hyun Yoon; Sonia S Hassan; Chaur-Dong Hsu; Lami Yeo; Ramiro Diaz-Primera; Julio Marin-Concha; Kia Lannaman; Ali Alhousseini; Hunter Gomez-Roberts; Aneesha Varrey; Angel Garcia-Sanchez; Maria Teresa Gervasi
Journal:  J Perinat Med       Date:  2021-01-26       Impact factor: 2.716

6.  Placental implications of peroxisome proliferator-activated receptors in gestation and parturition.

Authors:  Valerie Borel; Denis Gallot; Geoffroy Marceau; Vincent Sapin; Loïc Blanchon
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.